Skip to main content

The genomics-focused Illumina Accelerator backs five new companies

Illumina Accelerator, the genomics-focused startup accelerator backed by the publicly traded genetic sequencing pioneer Illumina Corp., has picked five startups for its seventh accelerator class, the company announced.

Wth technology addressing skin microbial therapeutics, fertility science, chronic disease alleviation, post traumatic stress disorder treatments, and services for the biopharmaceutical and clinical research industries; the startups selected by Illumina will have access to the company’s genomics and sequencing expertise, business coaching, lab and office space and an infusion of capital.

“At Illumina Accelerator, we provide entrepreneurs focused on breakthrough genomic sequencing applications key resources for success,” said Mostafa Ronaghi, Ph.D., Illumina’s Senior Vice President and Chief Technology Officer and co-founder of Illumina Accelerator, in a statement. “The selected companies receive advice and expertise to help guide strategies in business and financing, team building and more. Together, with our accomplished group of graduates, our newest investments are working to advance breakthrough applications in genomics, including therapeutics, diagnostics and direct-to-consumer applications.”

The companies in the program include:

 

  • DermBiont, Inc., a drug discovery and development company, developing skin microbial therapeutics.
  • MedAnswers, Inc., which is using big data and genetics to match would-be parents with a curated network of fertility experts and solutions to achieve healthier fertility outcomes, faster.
  • Mediphage Bioceuticals, Inc., based on research from the University of Waterloo, Ontario, Canada, this company is developing phage-based therapies to develop cures for chronic diseases.
  • TruGenomix Health, Inc., is a genomics company focused on advancing the treatment of post-traumatic stress disorder.
  • Unite Genomics, Inc., a data science spinout from Berkeley’s RISELab, uses machine learning for large-scale genomic analyses that can be applied in the biopharmaceutical and clinical research industries.

 

As an added perk for this seventh iteration of the program, accelerator companies also get access to Helix, the Illumina-affiliated genomics product marketplace that’s aiming to close out the year with roughly $300 million in total financing.

“Through our collaboration with Illumina Accelerator, we hope to provide innovative startups like MedAnswers access to Helix’s team of experts in bioinformatics, applied genomics, product development and consumer marketing to help transform their ideas into compelling consumer applications and services that make genomics relevant and accessible to all,” said Justin Kao, co-founder and Senior Vice President of Helix.

Companies selected for Illumina’s seed investment program, receive backing fro accredited investor through a convertible note and dollar-for-dollar matching funding through the company’s $40 million Illumina Accelerator Boost Capital, (if they raise between $1 million and $5 million of qualifying capital).

Applications for the accelerator’s eighth cohort are open now and are due by May 1.



from TechCrunch https://ift.tt/2KcTv9g
via IFTTT
Labels:

Comments

Post a Comment

Popular posts from this blog

The Silent Revolution of On-Device AI: Why the Cloud Is No Longer King

Introduction For years, artificial intelligence has meant one thing: the cloud. Whether you’re asking ChatGPT a question, editing a photo with AI tools, or getting recommendations on Netflix — those decisions happen on distant servers, not your device. But that’s changing. Thanks to major advances in silicon, model compression, and memory architecture, AI is quietly migrating from giant data centres to the palm of your hand. Your phone, your laptop, your smartwatch — all are becoming AI engines in their own right. It’s a shift that redefines not just how AI works, but who controls it, how private it is, and what it can do for you. This article explores the rise of on-device AI — how it works, why it matters, and why the cloud’s days as the centre of the AI universe might be numbered. What Is On-Device AI? On-device AI refers to machine learning models that run locally on your smartphone, tablet, laptop, or edge device — without needing constant access to the cloud. In practi...
1 comment
Read more

Apple’s AI Push: Everything We Know About Apple Intelligence So Far

Apple’s WWDC 2025 confirmed what many suspected: Apple is finally making a serious leap into artificial intelligence. Dubbed “Apple Intelligence,” the suite of AI-powered tools, enhancements, and integrations marks the company’s biggest software evolution in a decade. But unlike competitors racing to plug AI into everything, Apple is taking a slower, more deliberate approach — one rooted in privacy, on-device processing, and ecosystem synergy. If you’re wondering what Apple Intelligence actually is, how it works, and what it means for your iPhone, iPad, or Mac, you’re in the right place. This article breaks it all down.   What Is Apple Intelligence? Let’s get the terminology clear first. Apple Intelligence isn’t a product — it’s a platform. It’s not just a chatbot. It’s a system-wide integration of generative AI, machine learning, and personal context awareness, embedded across Apple’s OS platforms. Think of it as a foundational AI layer stitched into iOS 18, iPadOS 18, and m...
Post a Comment
Read more

Billionaire clothing dynasty heiress launches Everybody & Everyone to make fashion sustainable

Veronica Chou’s family has made its fortune at the forefront of the fast fashion business through investments in companies like Michael Kors and Tommy Hilfiger . But now, the heiress to an estimated $2.1 billion fortune is launching her own company, Everybody & Everyone , to prove that the fashion industry can be both environmentally sustainable and profitable. There’s no argument about the negative impacts of the fashion industry on the environment. The textiles industry primarily uses non-renewable resources — on the order of 98 million tons per year. That includes the oil to make synthetic fibers, fertilizers to grow cotton, and toxic chemicals to dye, treat, and produce the textiles used to make clothes. The greenhouse gas footprint from textiles production was roughly 1.2 billion tons of CO2 equivalent in 2015 — more than all international flights and maritime shipments combined (and a lot of those maritime shipments and international flights were hauling clothes). The lit...
Post a Comment
Read more